# Drug-Interaction Assessment of GSK3772701 in Healthy Male and Female Participants Aged 18 to 55 Years

> **NCT07670377** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 20 (actual)

## Conditions studied

- Malaria, Falciparum

## Interventions

- **DRUG:** Midazolam (MDZ)
- **DRUG:** GSK3772701

## Key facts

- **NCT ID:** NCT07670377
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2026-06-26
- **Primary completion:** 2026-08-24
- **Final completion:** 2026-08-24
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2026-09-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07670377

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07670377, "Drug-Interaction Assessment of GSK3772701 in Healthy Male and Female Participants Aged 18 to 55 Years". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07670377. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*